Part D has undergone the most significant structural overhaul of any part of Medicare in the past decade, and 2027 is another step in that redesign. If your medication costs have felt unpredictable in past years—falling into a “donut hole,” then a catastrophic phase, then starting over each January—2027 continues moving toward a simpler, capped structure. Here’s exactly what’s changing.
What This Article Covers
The New $700 Deductible
In 2027, the standard Part D deductible — the amount you pay out of pocket before your plan starts sharing drug costs — rises to $700, up from $615 in 2026. This is the maximum a plan is allowed to charge; some Part D plans offer a lower deductible or no deductible at all as a way to compete for enrollees, so it’s worth comparing plans rather than assuming you’ll pay the full $700. The deductible resets every January 1, regardless of how much you spent the prior year.
The $2,400 Out-of-Pocket Cap
This is the more consequential number for anyone on higher-cost medications. Once your true out-of-pocket spending on covered drugs reaches $2,400 in 2027 (up from $2,100 in 2026), you pay nothing further for covered medications for the rest of the calendar year. This cap was introduced as part of the Inflation Reduction Act’s redesign of Part D, replacing the old system’s confusing “coverage gap” or “donut hole” phase, where costs used to spike unpredictably partway through the year. The new structure is simpler: deductible, then a phase where you pay a percentage of costs, then the cap—and once you hit it, you’re done paying for the year.
Medicare also offers a Prescription Payment Plan option, letting you spread your out-of-pocket drug costs into monthly installments across the year rather than paying large amounts upfront early in the year—worth asking your plan about if you expect to hit the cap.
| Part D Cost Element | 2026 | 2027 |
|---|---|---|
| Annual deductible (maximum) | $615 | $700 |
| Out-of-pocket cap on covered drugs | $2,100 | $2,400 |
| Monthly insulin cap | $35 | $35 (unchanged) |
| Recommended adult vaccines | Free | Free (unchanged) |
| National base premium | $38.99 | Expected to rise |
Medicare Questionnaire
Click here to complete a short survey, and we will contact you directly!
Insulin Stays Capped at $35 a Month
One piece of good news that isn’t changing: the $35 monthly cap on covered insulin products remains in place for 2027, and it applies regardless of what phase of the Part D benefit you’re in—even during the deductible phase, when you’d otherwise be paying full cost for other medications. If you manage diabetes with insulin, this cap alone can represent significant, predictable savings compared to pre-reform pricing.
More Drugs Get Negotiated Prices in 2027
The Medicare Drug Price Negotiation Program, also created under the Inflation Reduction Act, allows Medicare to negotiate directly with manufacturers on prices for select high-spending drugs. Ten drugs had their negotiated, lower prices take effect for beneficiaries in 2026. For 2027, 15 additional drugs are set to see meaningful price reductions under negotiated agreements. Not every high-cost drug is included in this program — notably, GLP-1 medications have only recently begun entering the negotiation pipeline — so it’s worth checking whether your specific medications are affected rather than assuming broad price drops across the board.
What’s Happening to Part D Premiums
While the deductible and out-of-pocket structure are becoming more generous, premiums are moving the other direction. The Part D national base premium—used to help calculate late enrollment penalties and as a benchmark for private plan pricing—rose from $36.78 in 2025 to $38.99 in 2026, and further increases are widely expected in 2027. Some of this reflects a broader trend: the abundance of $0-premium and low-premium Part D plans in recent years helped push the average premium down, but as those plans become less financially viable for insurers under the new cost structure, some carriers are expected to pull them from the market in 2027, which could push average premiums higher even if any single plan’s pricing seems reasonable.
What to Do Before Open Enrollment
Because your plan’s specific formulary, premium, and pharmacy network can all change year to year even while the overall Part D structure stays similar, the most important action item is a familiar one: don’t let your Part D plan auto-renew without checking it first. When your Annual Notice of Change arrives in September, confirm your current medications are still covered at a reasonable tier, verify your pharmacy is still in network, and run your medication list through Medicare’s Plan Finder tool to compare your total annual cost—not just the premium—against other available plans. Our full walkthrough of this process is at 2027 Open Enrollment Checklist: What to Do Before December 7.
A Real-World Example of the New Structure
To see how the 2027 changes actually play out, consider someone managing a chronic condition with an annual drug spend of $3,000 at retail prices. Under the 2027 structure, they’d first pay up to $700 out of pocket during the deductible phase (or less, depending on their specific plan’s deductible). After that, they’d pay a percentage of costs during the next phase until their total out-of-pocket spending reaches $2,400—at which point, for the rest of the calendar year, their covered medications are free. In practical terms, this means their maximum possible drug spending for the year is capped at $2,400, regardless of how expensive their medications are at retail—a dramatic improvement over the pre-reform system, where high-cost medications could result in thousands of dollars in coinsurance even after passing through the old “donut hole.”
This predictability is precisely why the Prescription Payment Plan option matters for some enrollees: rather than potentially paying a large share of that $2,400 cap in the first few months of the year (since many chronic medications are taken and billed monthly, and some specialty drugs are billed with large costs upfront), the payment plan lets you convert that $2,400 into predictable monthly installments spread across the year, which can meaningfully ease cash-flow pressure for retirees on fixed incomes.
It’s worth noting that the Prescription Payment Plan doesn’t reduce what you owe—it only spreads the timing of when you pay it—so it’s most useful for people who would otherwise face a cash-flow crunch early in the year, rather than a way to lower total annual drug costs. Enrollment in the payment plan is optional and must generally be requested through your Part D plan, either during Open Enrollment or when you first anticipate high drug costs during the year.
Compare 2027 Part D Plans for Your Medications
See which Part D and Medicare Advantage plans cover your
specific medications at the lowest total annual cost in your
area.
Frequently Asked Questions
What is the Medicare Part D deductible for 2027?
The Part D annual deductible is rising to $700 in 2027, up from $615 in 2026. Not all plans charge the full deductible—some have lower or no deductible, which is worth checking during Open Enrollment.
What is the Medicare Part D out-of-pocket cap for 2027?
The annual out-of-pocket cap on covered drugs is rising to $2,400 in 2027, up from $2,100 in 2026. Once you hit this cap, you pay nothing more for covered drugs for the rest of the year.
Is insulin still capped at $35 a month in 2027?
Yes. The $35 monthly insulin cap for covered insulin products remains in place for 2027, regardless of what phase of the Part D benefit you’re in.
What is Medicare drug price negotiation?
It’s a program under the Inflation Reduction Act allowing Medicare to directly negotiate lower prices with drug manufacturers for select high-cost medications. Ten drugs that had negotiated prices take effect in 2026, and 15 more are set to have discounted prices in 2027.
Will my Part D premium go up in 2027?
Likely, though it varies by plan. The Part D national base premium rose from $36.78 in 2025 to $38.99 in 2026, and further increases are expected for 2027 as insurers adjust to rising drug costs and pull back some low-premium plans.
Medicare Questionnaire
Click here to complete a short survey, and we will contact you directly!
Figures reflect publicly available CMS Part D data and projections as of August 2026.
Final 2027 plan-specific premiums and formularies are released during Open Enrollment; always confirm current details at Medicare.gov.
Senior Affair is not affiliated with the federal Medicare program.
